Haisco Pharmaceutical Group Co Ltd to Make a $10 Million Equity Investment in Pneuma Respiratory and Enters into a Distribution Agreement
"...Haisco Pharmaceutical Group Co Ltd, a China-based company focused on the research and development and marketing of therapeutic drugs, has agreed to make a $10 millionequity investment in Pneuma Respiratory. As part of the agreement, Haisco Pharmaceutical Group is to receive rights to distribute Pneuma Respiratory's pharmaceutical products in China. Haisco will be responsible for funding China regulatory filings."
The complete article can be found here.